Phase II Trial of Allovectin-7® for Metastatic Melanoma
Public ClinicalTrials.gov record NCT00044356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma
Study identification
- NCT ID
- NCT00044356
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vical
- Industry
- Enrollment
- 133 participants
Conditions and interventions
Conditions
Interventions
- Allovectin-7® Genetic
Genetic
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2001
- Primary completion
- Jul 31, 2004
- Completion
- Aug 31, 2004
- Last update posted
- Jul 6, 2011
2001 – 2004
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| University of Arkansas Cancer Research Center | Little Rock | Arkansas | 72205 | — |
| Comprehensive Blood and Cancer Center | Bakersfield | California | 48202 | — |
| University of California, San Francisco | San Francisco | California | 94115 | — |
| University of Colorado Cancer Center | Denver | Colorado | 80010 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Louisiana State University Medical Center | New Orleans | Louisiana | 70112 | — |
| Hematology Oncology Associates of Baltimore | Baltimore | Maryland | 21236 | — |
| North Memorial Health Care | Robbinsdale | Minnesota | 55422 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| The Melanoma Center of Saint Louis | St Louis | Missouri | 63131 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00044356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 6, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00044356 live on ClinicalTrials.gov.